• TECHNOLOGY

    Elon Musk’s Brain Chip Receives FDA Approval

    Clan Reporters Posted on

    Elon Musk’s brain-chip startup, Neuralink, has been granted the FDA’s “breakthrough device” designation for its experimental implant, Blindsight, aimed at helping restore vision.

    The device, called ‘Blindsight,’ is designed to restore vision in individuals with complete or partial blindness, including those with non-functional optic nerves.

    “We have received Breakthrough Device Designation from the FDA for Blindsight.

    “Join us in our quest to bring back sight to those who have lost it. Apply to our Patient Registry and openings on our career page,” Neuralink wrote on its X page on Tuesday.

    Elon Musk’s brain-chip startup, Neuralink, announced the milestone for its Blindsight technology via its social media this week

    According to reports, the FDA awards its breakthrough designation to medical devices that treat or diagnose life-threatening conditions, expediting their development and review.

    Musk also announced the update on his X social media platform, highlighting Blindsight’s potential to restore vision in even the most severe blindness cases.

    “The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see.

    “Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time.

    “To set expectations correctly, the vision will at first be low resolution, like Atari graphics, but eventually it has the potential to be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge.” Musk wrote on X.com.

    Neuralink, co-founded by Elon Musk in 2016, specialises in developing innovative brain-computer interfaces to transform treatments for neurological disorders. It’s technology includes a brain implant that reads neural signals and wirelessly transmits them to external devices, including computers and mobile devices.

    Neuralink is also developing an implant that enables paralyzed individuals to control digital devices with their thoughts and is also reported to be conducting a clinical trial with three participants to evaluate the device’s effectiveness in aiding individuals with spinal cord injuries.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    Clan Reporters
    Clan Reporters is a Nigerian newspaper founded in 2014 by Paul Omo Okojie, a media consultant, communicator, and entrepreneur. Published in hard copy print format, the newspaper was established to deliver timely news, in-depth reporting, and relevant commentary on issues affecting Nigerian communities, with a focus on politics, society, business, and grassroots affairs. As both the founder and the guiding force behind the newspaper, Paul Omo Okojie also leads OMC Okojie Media Consultants (often shortened to OMC), the media firm responsible for the editorial direction, strategic communications, and overall operations of Clan Reporters. Under his leadership, the newspaper has aimed to blend professional journalism with community engagement, giving voice to local stories and perspectives often overlooked in mainstream media. Okojie’s background in journalism and media consultancy has shaped Clan Reporters into a platform committed to credibility, accountability, and service to its readership. Over the years, the publication has sought to uphold high standards of reporting while fostering informed public discourse in Nigeria.
    View all posts

    You Might Also Like